Review high-stakes AI decisions before enabling execution

When an AI output can affect health, access to services or another consequential outcome, the review needs to cover what happens after the model responds. Who can act on the result, what can stop an inappropriate action and what evidence supports the intended use? The following is a proposed engineering review structure, not a clinical protocol, legal determination or finding from a deployment study.

Define the decision and its consequences

Document the intended users, affected people, input data and permitted output. Separate a suggestion shown to a trained reviewer from an automated decision or a command that directly changes the outside world. Describe plausible harms from incorrect output, missing output and delayed action; the relevant consequences depend on the application.

Have accountable domain and legal specialists establish the applicable requirements before selecting controls. For example, the FDA's January 2026 clinical decision support guidance addresses which software functions are excluded from the device definition and the continuing application of its policies to functions that meet that definition. That scope cannot be reduced to a rule that every AI recommendation is either regulated or exempt.

Put authority at a controlled execution point

Map every route by which an output can become an action, including background jobs, retries and fallback modes. Specify which actions are permitted automatically and which need an identified authorized person. Enforce those permissions in the application or control system rather than accepting the model's own description of what it is allowed to do.

A proposed review should test that a rejected or expired approval cannot be reused and that a later change to the underlying case triggers the required reassessment. It should also examine what happens when the authorization service is unavailable. Select the permitted fallback for the actual context; there is no universal safe response that fits every high-stakes process.

Test whether oversight can change the outcome

A review button alone does not demonstrate effective oversight. Ask whether the reviewer receives the relevant evidence, understands the limitations, has enough time and can reject or escalate the proposal before execution. Record who handles disagreements and who owns the final operational decision.

Rehearse interruption, recovery and handover using controlled scenarios. Include an unavailable reviewer, conflicting evidence, a stale case and a queue that grows beyond the agreed service limit. Define acceptable outcomes in advance. These are suggested tests, not claims that a particular design has passed them.

Choose evidence that matches the intended use

Evaluate errors according to their consequences instead of reporting a single aggregate accuracy score alone. Where relevant to the use and supported by appropriate data, inspect results across affected groups, input conditions and operational settings. Document sample limitations and unresolved cases rather than presenting a test set as proof of universal safety.

Set acceptance criteria with domain specialists. A model confidence score is not a universal threshold for safe action. Measure delays and recovery behavior as well as output quality, because the application must operate within the constraints established for its particular decision.

Keep an accountable record without overstating it

Record the versions, relevant input provenance, proposal, authorization and observed outcome needed for investigation. Restrict sensitive information and access according to the applicable requirements. Integrity controls can help reveal alteration of records when properly designed, but a hash alone does not prove that an original decision was correct or that every event was recorded.

The NIST AI Risk Management Framework is explicitly voluntary. It can inform a risk-management discussion; using it is not a certification or a substitute for sector-specific obligations. End the review with named owners, unresolved risks, monitoring criteria and conditions for stopping or reassessing the deployment.